Abstract
Background and Aims: Bempedoic acid (BemA), an ATP-citrate lyase (ACLY) inhibitor, reduces cholesterol and fatty acid synthesis. We explored BemA effects in the early stage of non-alcoholic fatty liver disease in a diet-induced rat model of hepatic steatosis.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
